Jared Baeten

• Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention

  Open Access•Marla Husnik, Elizabeth R Brown et al.•ARTICLE•AIDS and Behavior•2021

  Añadir item

• Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial

  Open Access•Ashley Mayo, Erica N Browne et al.•ARTICLE•AIDS and Behavior•2021

  Añadir item

  We evaluated the acceptability of the 25 mg dapivirine vaginal ring (DVR) as an HIV prevention intervention and its influence on DVR adherence in the MTN-020/ASPIRE phase III trial. Acceptability measures were captured using ACASI at month 3 and end of product use (median 24 months, IQR 15-30). Monthly returned rings were classified as nonadherent if dapivirine release rate was ≤ 0.9 mg/month. Associations between acceptability measures and nonad…

• The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence

  Open Access•Marie C D Stoner, Elizabeth R Brown et al.•ARTICLE•AIDS and Behavior•2021

  Añadir item

• Safer conception among HIV-1 serodiscordant couples in East Africa

  Kerry Hancuch, Jared M Baeten et al.•ARTICLE•AIDS Care•2018

  Añadir item

  For HIV-1 serodiscordant couples, HIV-1 exposure and risk of transmission is heightened during pregnancy attempts, but safer conception strategies can reduce risk. As safer conception programs are scaled up, understanding couples' preferences and experiences can be useful for programmatic recommendations. We followed 1013 high-risk, heterosexual HIV-1 serodiscordant couples from Kenya and Uganda for two years in an open-label delivery study of in…

• Safer conception among HIV-1 serodiscordant couples in East Africa

  Kerry Hancuch, Jared M Baeten et al.•ARTICLE•AIDS Care•2018

  Añadir item

  For HIV-1 serodiscordant couples, HIV-1 exposure and risk of transmission is heightened during pregnancy attempts, but safer conception strategies can reduce risk. As safer conception programs are scaled up, understanding couples' preferences and experiences can be useful for programmatic recommendations. We followed 1013 high-risk, heterosexual HIV-1 serodiscordant couples from Kenya and Uganda for two years in an open-label delivery study of in…

• Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention

  Open Access•Marla Husnik, Elizabeth R Brown et al.•ARTICLE•AIDS and Behavior•2021

  Añadir item

• Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial

  Open Access•Ashley Mayo, Erica N Browne et al.•ARTICLE•AIDS and Behavior•2021

  Añadir item

  We evaluated the acceptability of the 25 mg dapivirine vaginal ring (DVR) as an HIV prevention intervention and its influence on DVR adherence in the MTN-020/ASPIRE phase III trial. Acceptability measures were captured using ACASI at month 3 and end of product use (median 24 months, IQR 15-30). Monthly returned rings were classified as nonadherent if dapivirine release rate was ≤ 0.9 mg/month. Associations between acceptability measures and nonad…

• The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence

  Open Access•Marie C D Stoner, Elizabeth R Brown et al.•ARTICLE•AIDS and Behavior•2021

  Añadir item

HIV/AIDS Research and Interventions (4 obras) · Medicine (4 obras) · Adolescent Sexual and Reproductive Health (3 obras) · Environmental health (3 obras) · Family planning (3 obras) · HIV, Drug Use, Sexual Risk (3 obras) · Population (3 obras) · Research methodology (3 obras) · Vaginal ring (3 obras) · Family medicine (2 obras)